%0 Journal Article
%T Seroprevalence of SARS-CoV-2 among Blood Donors in the Republic of Congo
%A Serge Oscar Mokono
%A Edwige Paola Chancelle Louanga Nanitelamio
%A Chaldam Jesp¨¨re Mbani
%A Aude Tabapika
%A Taty Taty
%A Nina Esther Ngoyi N¨Ĥe Ontsira
%A Donatien Moukassa
%J Open Journal of Blood Diseases
%P 124-132
%@ 2164-3199
%D 2022
%I Scientific Research Publishing
%R 10.4236/ojbd.2022.124013
%X Corona Virus Disease 2019 (COVID-19) is a highly transmissible and pathogenic viral infection
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which erupted in Wuhan, China, in 2019 and has spread worldwide [1]. The
objective of this study was to assess the seroprevalence of SARS-CoV-2 among blood donors in the Republic of Congo. Method: This is an analytical and cross-sectional study that was carried out during the
period from July to December 2021. Biological analyses were performed with the
serological tests n2019 rapid IgG/IgM from Beijing Diagreat Biotechnologies and
antigen tests from Abbot using the serum for the detection of
anti-SARS-Cov-2 antibodies and nasal mucus for the detection of
SARS-Cov-2 antigens. Statistical analysis was performed using SPSS version 22. The Results: Out of 2553 donors recruited in our study, we observed a predominance of male sex with 86.1%
or a ratio of 6.19, the age group of 18 - 30
years was dominant with 45.9%, family donation represented 59.2%, the dominant
profession was workers with 46.9% and the dominant blood group was O Rh
positive with 54%. The prevalence of anti-SRAS-CoV-2 antibodies and antigens were respectively 31.4%
for anti-SRAS CoV-2 IgG antibodies, 36.7% for anti-SRAS CoV-2 IgM antibodies
and 2.93% for SARS-CoV-2 antigen.
%K Seroprevalence
%K Blood Donors
%K Anti IgM Antibody
%K Anti IgG Antibody
%K Antigen
%K SARS-CoV-2
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=122132